Besides breast cancer, multiple other cancers exhibited TINCR upregulation, including adrenocortical carcinoma (ACC), bladder urothelial carcinoma (BLCA), cervical and endocervical cancers (CESC), lymphoid neoplasm-diffuse large B-cell lymphoma (DLBC), acute myeloid leukemia (LAML), lung squamous-cell carcinoma (LUSC), pancreatic adenocarcinoma (PAAD), testicular germ-cell tumors (TGCT), thyroid carcinoma (THCA), and thymoma (THYM), according to an analysis of the GEPIA database (Fig. 2a). This evidence concerns the gene TINCR and bladder transitional cell carcinoma.